- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Carmel Today
By the People, for the People
NeurAxis to Host Q4 and Full Year 2025 Results Call
Medical tech company NeurAxis will report financial results and host a conference call on March 19, 2026.
Mar. 13, 2026 at 5:33am
Got story updates? Submit your updates here. ›
NeurAxis, Inc., a medical technology company focused on neuromodulation therapies, will report summarized financial results for its fourth quarter and fiscal year 2025 on Thursday, March 19, 2026, before market open. The company has scheduled a conference call for the same day at 9:00 am ET to review the results.
Why it matters
NeurAxis is a publicly traded company developing innovative neuromodulation therapies to address chronic and debilitating conditions. This earnings call and business update will provide investors and the public with key insights into the company's financial performance and progress on its product pipeline.
The details
NeurAxis' IB-Stim product, a Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, is FDA cleared for functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD), and FD-related nausea symptoms in patients 8 years and older. The company is also conducting additional clinical trials of PENFS in multiple pediatric and adult conditions.
- NeurAxis will report Q4 and full year 2025 results on Thursday, March 19, 2026, before market open.
- The company will host a conference call on Thursday, March 19, 2026, at 9:00 am ET.
The players
NeurAxis, Inc.
A medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults.
What’s next
Investors and the public can access the live webcast of the conference call on NeurAxis' investor relations website or by registering for the call-in details.
The takeaway
This earnings report and business update from NeurAxis will provide important insights into the company's financial performance and progress on its innovative neuromodulation product pipeline, which aims to address significant unmet medical needs.
